Tools

Peptide dosage chart

The doses used in published studies for every peptide on Upzo, with the study next to each one. They are not a recommendation. For the arithmetic of mixing a vial, use the calculator.

Doses used in studies, by peptide

Doses as reported by each study. Not a recommendation.
PeptideDose used in studiesRouteStudyVials
AHK-Cu10^-12 to 10^-9 M AHK-Cu in culture; Dose not given in the abstract; see the paperAdded to culture medium; —Pyo HK 2007, Jung JI 201850 mg
BPC-15714 studies, see BPC-157 dosesSeveral—10 mg
CJC-12956 studies, see CJC-1295 dosesSeveral—10 mg
Epitalon9 studies, see Epitalon doses——10 mg
GHK-Cu10 studies, see GHK-Cu dosesSeveral—50 mg, 100 mg
IGF-1 LR37 studies, see IGF-1 LR3 dosesSeveral—1 mg
Ipamorelin10 studies, see Ipamorelin dosesSeveral—10 mg
Kisspeptin-1012 studies, see Kisspeptin-10 dosesSeveral—10 mg
MOTS-c8 studies, see MOTS-c dosesIntraperitoneal injection—10 mg
NAD+8 studies, see NAD+ dosesSeveral—1,000 mg
PT-1418 studies, see PT-141 dosesSeveral—10 mg
Retatrutide9 studies, see Retatrutide dosesSubcutaneous, once weekly—10 mg, 20 mg, 30 mg
Selank8 studies, see Selank dosesSeveral——
Semaglutide15 studies, see Semaglutide dosesSeveral——
Semax8 studies, see Semax dosesSeveral——
SS-3112 studies, see SS-31 dosesSeveral—10 mg
TB-50012 studies, see TB-500 dosesSeveral—10 mg
Tesamorelin9 studies, see Tesamorelin dosesSeveral—10 mg, 20 mg
Thymosin Alpha-110 studies, see Thymosin Alpha-1 dosesSeveral——
Tirzepatide12 studies, see Tirzepatide dosesSubcutaneous, once weekly—20 mg

Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.